Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials
出版年份 2022 全文链接
标题
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials
作者
关键词
-
出版物
JAMA Psychiatry
Volume -, Issue -, Pages -
出版商
American Medical Association (AMA)
发表日期
2022-01-27
DOI
10.1001/jamapsychiatry.2021.3990
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Registry-based studies: What they can tell us, and what they cannot
- (2021) Heidi Taipale et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Assessing the efficacy‐effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population‐based, real‐world data for contemporary parenteral cancer therapeutics
- (2020) Cameron M. Phillips et al. CANCER
- Generating comparative evidence on new drugs and devices after approval
- (2020) Andrea Cipriani et al. LANCET
- Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences
- (2020) Heidi Taipale et al. NORDIC JOURNAL OF PSYCHIATRY
- Early intervention in psychiatry: scotomas, representativeness, and the lens of clinical populations
- (2019) Jai L. Shah et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- Treatment Recommendations for Tardive Dyskinesia
- (2019) Lucia Ricciardi et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Bridging the Efficacy–Effectiveness Gap in HIV Programs
- (2019) Jacob Bor et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer
- (2018) Christine M. Cramer-van der Welle et al. EUROPEAN RESPIRATORY JOURNAL
- A comparison of neurocognition and functioning in first episode psychosis populations: do research samples reflect the real world?
- (2018) Emily Kline et al. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
- The Representativeness of Participants With Severe Mental Illness in a Psychosocial Clinical Trial
- (2018) John Lally et al. Frontiers in Psychiatry
- Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia—A Nationwide Study With 20-Year Follow-up
- (2017) Heidi Taipale et al. SCHIZOPHRENIA BULLETIN
- Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
- (2017) Jari Tiihonen et al. JAMA Psychiatry
- From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)
- (2015) Antti Tanskanen et al. BMC Medical Informatics and Decision Making
- Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia
- (2015) Larry Alphs et al. JOURNAL OF CLINICAL PSYCHIATRY
- A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
- (2015) Tessa Kennedy-Martin et al. Trials
- The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
- (2015) Eric I. Benchimol et al. PLOS MEDICINE
- Observational, Pragmatic, and Clinical Trials in Bipolar Disorder
- (2009) Eduard Vieta JOURNAL OF CLINICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More